Equities researchers at DA Davidson raised their FY2026 earnings per share (EPS) estimates for Amplitude in a report issued on Tuesday, March 11th. DA Davidson analyst C. Wright now forecasts that the ...

Amplitude (NASDAQ:AMPL – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They currently have a $16.

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

SAN FRANCISCO, March 07, 2025--(BUSINESS WIRE)--Amplitude (Nasdaq: AMPL), the leading digital analytics platform, will host its previously announced investor day on Monday, March 10, 2025 beginning at ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

PAI Partners has entered exclusive talks to sell majority stake in Amplitude Surgical, a European medical technology business, alongside the company’s management team and two minority shareholders.

Meeting to be held in Boston on March 13 hosted by KeyBanc.Light Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

RBC Capital analyst Gordon Ramsay upgraded Amplitude Energy (COPJF) to Outperform from Sector Perform with a price target of A$0.28, up from ...

Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based ...

Regulatory News: Zydus Lifesciences Limited2 ("Zydus"), a global innovation-driven lifesciences company has entered into exclusive negotiations to purchase3 from PAI Partners and Amplitude Surgical’s ...